Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|January 5, 2020
Prostate Cancer Energetics and BiosynthesisChenchu Lin, Travis C Salzillo, David A Bader, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Improve the Efficacy of B7-H3-Targeting Antibody-Drug Conjugate DS-7300a in TP53-deficient Tumors by Inducing FerroptosisJavier Leo, Feiyu Chen, Wei Shi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 29, 2012
Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alphaBridgette M Collins-Burow, James W Antoon, Daniel E Frigo, et al.
Endocrinology|May 8, 2023
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate CancerJavier Leo, Eleonora Dondossola, Kaitlin J Basham, et al.
Cancer Research|September 17, 2008
Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeuticAndrea B Sherk, Daniel E Frigo, Christine G Schnackenberg, et al.
Cancer Research|September 5, 2006
AKT regulation of estrogen receptor beta transcriptional activity in breast cancerBich N Duong, Steven Elliott, Daniel E Frigo, et al.
Animal Genetics|June 10, 2014
Quantitative trait loci mapping for conjugated linoleic acid, vaccenic acid and ∆(9) -desaturase in Italian Brown Swiss dairy cattle using selective DNA poolingM G Strillacci, E Frigo, F Canavesi, et al.
Molecular Metabolism|September 13, 2025
Myeloid-specific CAMKK2 deficiency protects against diet-induced obesity and insulin resistance by rewiring metabolic gene expression and enhancing energy expenditureAndrea R Ortiz, Kevin Nay, Brittany A Stork, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Oncogene|February 3, 2021
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signalingChenchu Lin, Alicia M Blessing, Thomas L Pulliam, et al.
Pageof 8